The CRB business model is based on investing in business opportunities in the area of biotechnology and establishing an outflow strategy to obtain returns which multiply the investment severalfold.

CRB forms companies with scientific groups that, supported by professional management, develop applications acquired by the research centres, until their validation or concept check.

In the selection of companies, CRB has developed and used criteria to ensure a balanced portfolio, in order to reduce its risks.

The stages of the process are as follows:

1. Project selection
2. Forming, financing, and managing the companies in the early stages
3. Financing and managing in later stages
4. Validation of products and services
5. Licensing of patents or sale of companies